Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cervical Cancer, June 2017

Free Subscription


Abstracts

Retrieve all available abstracts of the following 153 articles:
HTML format


 

Single Articles

  1. REUZE S, Orlhac F, Chargari C, Nioche C, et al
    Prediction of cervical cancer recurrence using textural features extracted from 18F-FDG PET images acquired with different scanners.
    Oncotarget. 2017 May 15. doi: 10.18632/oncotarget.17856.
    Abstract    

    Abstract available

  2. VAN KALLEVEEN IML, Hoogendam JP, Raaijmakers AJE, Visser F, et al
    Boosting the SNR by adding a receive-only endorectal monopole to an external antenna array for high-resolution, T2 -weighted imaging of early-stage cervical cancer with 7-T MRI.
    NMR Biomed. 2017 Jun 2. doi: 10.1002/nbm.3750.
    Abstract    

    Abstract available

  3. HARIPRASAD R, Sodhani P, Gupta S, Sriram L, et al
    Opportunistic cervical cancer screening of women visitors at a trade fair in India.
    Indian J Med Res. 2017;145:144-146.
    Abstract    



  4. LEE EA, Shin J, Hwang EJ, Lee JW, et al
    Breast and Cervical Cancer Screening Behavior in Female Cancer Survivors: The Korea National Health and Nutrition Examination Survey, 2007-2012.
    Korean J Fam Med. 2017;38:116-121.
    Abstract    

    Abstract available

  5. DI MARTINO G, Crivellaro C, De Ponti E, Bussi B, et al
    Indocyanine Green Versus Radiotracer +/- Blue Dye for Sentinel Lymph Node Mapping in > Stage IB1 Cervical Cancer (> 2 cm).
    J Minim Invasive Gynecol. 2017 May 29. pii: S1553-4650(17)30305.
    Abstract    

    Abstract available

  6. YE H, Zhang Y, Wang Y, Xia J, et al
    The restraining effect of baicalein and U0126 on human cervical cancer cell line HeLa.
    Mol Med Rep. 2017 May 30. doi: 10.3892/mmr.2017.6648.
    Abstract    

    Abstract available

  7. WANG X, Gao P, Wang M, Liu J, et al
    Feedback between E2F1 and CIP2A regulated by human papillomavirus E7 in cervical cancer: implications for prognosis.
    Am J Transl Res. 2017;9:2327-2339.
    Abstract    

    Abstract available

  8. DE THURAH L, Bonde J, Hoa Lam JU, Rebolj M, et al
    Concordant testing results between various Human Papillomavirus assays in primary cervical cancer screening: systematic review.
    Clin Microbiol Infect. 2017 May 27. pii: S1198-743X(17)30280.
    Abstract    

    Abstract available

  9. MOORE DE PERALTA A, Holaday B, Hadoto IM
    Cues to Cervical Cancer Screening Among U.S. Hispanic Women.
    Hisp Health Care Int. 2017;15:5-12.
    Abstract    

    Abstract available

  10. YAKU H, Yoshida Y, Okazawa H, Kiyono Y, et al
    Highly Sensitive Telomerase Assay Insusceptible to Telomerase and PCR Inhibitors for Cervical Cancer Screening Using Scraped Cells.
    Anal Chem. 2017 May 30. doi: 10.1021/acs.analchem.6b04777.
    Abstract    

    Abstract available

  11. MABUCHI S, Matsumoto Y, Komura N, Sawada M, et al
    The efficacy of surgical treatment of recurrent or persistent cervical cancer that develops in a previously irradiated field: a monoinstitutional experience.
    Int J Clin Oncol. 2017 May 27. doi: 10.1007/s10147-017-1134.
    Abstract    

    Abstract available

  12. OPRESCU DN, Bacalbasa N, Balescu I, Filipescu A, et al
    Urinary Tract Resections in Advanced-stage Cervical Cancer - A Series of Eight Cases.
    Anticancer Res. 2017;37:3271-3276.
    Abstract    

    Abstract available

  13. MAZERON R, Gouy S, Escande A, Dumas I, et al
    Locally advanced cervical cancer: Is it relevant to report image-guided adaptive brachytherapy using point A dose?
    Brachytherapy. 2017 May 24. pii: S1538-4721(17)30347.
    Abstract    

    Abstract available

  14. ZHANG JJ, Wang DD, Du CX, Wang Y, et al
    Long Noncoding RNA ANRIL Promotes Cervical Cancer Development By Acting as a Sponge of miR-186.
    Oncol Res. 2017 May 22. doi: 10.3727/096504017X14953948675449.
    Abstract    

    Abstract available

  15. PRYOR RJ, Masroor N, Stevens M, Sanogo K, et al
    Cervical cancer screening in rural mountainous Honduras: knowledge, attitudes and barriers.
    Rural Remote Health. 2017;17:3820.
    Abstract    

    Abstract available

  16. HE Y, Zhao Q, Geng YN, Yang SL, et al
    Clinical analysis of cervical intraepithelial neoplasia with vaginal intraepithelial neoplasia.
    Medicine (Baltimore). 2017;96:e6700.
    Abstract    

    Abstract available

  17. HU SY, Zhang WH, Li SM, Li N, et al
    Pooled analysis on the necessity of random 4-quadrant cervical biopsies and endocervical curettage in women with positive screening but negative colposcopy.
    Medicine (Baltimore). 2017;96:e6689.
    Abstract    

    Abstract available

  18. MCDONALD SA, Qendri V, Berkhof J, de Melker HE, et al
    Disease burden of human papillomavirus infection in the Netherlands, 1989-2014: the gap between females and males is diminishing.
    Cancer Causes Control. 2017;28:203-214.
    Abstract    

    Abstract available

  19. NELSON EJ, Maynard BR, Loux T, Fatla J, et al
    The acceptability of self-sampled screening for HPV DNA: a systematic review and meta-analysis.
    Sex Transm Infect. 2017;93:56-61.
    Abstract    

    Abstract available

  20. CHANG HK, Kim DS, Chae JJ, Kim M, et al
    Inhibition of ERK activity enhances the cytotoxic effect of peroxisome proliferator-activated receptor gamma (PPARgamma) agonists in HeLa cells.
    Biochem Biophys Res Commun. 2017;482:843-848.
    Abstract    

    Abstract available

  21. SUNDSTROM K, Lu D, Elfstrom KM, Wang J, et al
    Follow-up of women with cervical cytological abnormalities showing atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion: a nationwide cohort study.
    Am J Obstet Gynecol. 2017;216:48.
    Abstract    

    Abstract available

  22. JIN H, Lu X, Ni J, Sun J, et al
    HOTAIR rs7958904 polymorphism is associated with increased cervical cancer risk in a Chinese population.
    Sci Rep. 2017;7:3144.
    Abstract    

    Abstract available

  23. SONG X, Han Y, Shao Y, Gu W, et al
    Assessment of local treatment modalities for FIGO stage IB-IIB cervical cancer: A propensity-score matched analysis based on SEER database.
    Sci Rep. 2017;7:3175.
    Abstract    

    Abstract available

  24. MBACHU C, Dim C, Ezeoke U
    Effects of peer health education on perception and practice of screening for cervical cancer among urban residential women in south-east Nigeria: a before and after study.
    BMC Womens Health. 2017;17:41.
    Abstract    

    Abstract available

  25. HOU R, Wang D, Lu J
    MicroRNA-10b inhibits proliferation, migration and invasion in cervical cancer cells via direct targeting of insulin-like growth factor-1 receptor.
    Oncol Lett. 2017;13:5009-5015.
    Abstract    

    Abstract available

  26. LI Q, Shen F, Wang C
    TUC338 promotes cell migration and invasion by targeting TIMP1 in cervical cancer.
    Oncol Lett. 2017;13:4526-4532.
    Abstract    

    Abstract available

  27. ZHANG X, Wang Y, Cao Y, Zhang X, et al
    Increased CCL19 expression is associated with progression in cervical cancer.
    Oncotarget. 2017 May 18. doi: 10.18632/oncotarget.17982.
    Abstract    

    Abstract available

  28. MAJOR I, McConville C
    Vaginal drug delivery for the localised treatment of cervical cancer.
    Drug Deliv Transl Res. 2017 Jun 8. doi: 10.1007/s13346-017-0395.
    Abstract    

    Abstract available

  29. BASTO DL, Vidal JP, Pontes VB, Felix SP, et al
    Genetic diversity of human papillomavirus types 35, 45 and 58 in cervical cancer in Brazil.
    Arch Virol. 2017 Jun 9. doi: 10.1007/s00705-017-3439.
    Abstract    

    Abstract available

  30. KADOYA N, Miyasaka Y, Yamamoto T, Kuroda Y, et al
    Evaluation of rectum and bladder dose accumulation from external beam radiotherapy and brachytherapy for cervical cancer using two different deformable image registration techniques.
    J Radiat Res. 2017 Jun 8:1-9. doi: 10.1093.
    Abstract    

    Abstract available

  31. KOTRONOULAS G, O'Brien F, Simpson MF, Maguire R, et al
    Feasibility and Acceptability of the Use of Patient-Reported Outcome Measures in the Delivery of Nurse-Led, Supportive Care to Women With Cervical Cancer.
    Clin Nurse Spec. 2017;31:E1-E10.
    Abstract    

    Abstract available

  32. PHILLIPS P, Phillips J
    Hysterectomy With Radiotherapy or Chemotherapy or Both for Women With Locally Advanced Cervical Cancer.
    Clin Nurse Spec. 2017;31:189-190.
    Abstract    



  33. FENG Y, Wang Y, Jiang C, Fang Z, et al
    Nicotinamide induces mitochondrial-mediated apoptosis through oxidative stress in human cervical cancer HeLa cells.
    Life Sci. 2017 Jun 4. pii: S0024-3205(17)30277-1. doi: 10.1016/j.lfs.2017.
    Abstract    

    Abstract available

  34. GARCIA-GARCIA A, Coronel-Martinez J, Leon DC, Romero-Figueroa MDS, et al
    Detection of Actinomyces spp. in cervical exudates from women with cervical intraepithelial neoplasia or cervical cancer.
    J Med Microbiol. 2017 Jun 8. doi: 10.1099/jmm.0.000485.
    Abstract    

    Abstract available

  35. KHATUN S, Huda AQ, Begum SK, Ferdous J, et al
    Evaluation of Pelvic Lymphadenectomy during Radical Hysterectomy for Cervical Cancer.
    Mymensingh Med J. 2017;26:287-292.
    Abstract    

    Abstract available

  36. TANG J, Li B, Hong S, Liu C, et al
    Punicalagin suppresses the proliferation and invasion of cervical cancer cells through inhibition of the beta-catenin pathway.
    Mol Med Rep. 2017 Jun 6. doi: 10.3892/mmr.2017.6687.
    Abstract    

    Abstract available

  37. YANG P, Chen N, Yang D, Crane J, et al
    The ratio of serum Angiopoietin-1 to Angiopoietin-2 in patients with cervical cancer is a valuable diagnostic and prognostic biomarker.
    PeerJ. 2017;5:e3387.
    Abstract    

    Abstract available

  38. ZHOU J, Zhang WW, Wu SG, He ZY, et al
    The prognostic value of histologic subtype in node-positive early-stage cervical cancer after hysterectomy and adjuvant radiotherapy.
    Int J Surg. 2017 Jun 2. pii: S1743-9191(17)30459.
    Abstract    

    Abstract available

  39. HANG D, Jia M, Ma H, Zhou J, et al
    Independent prognostic role of human papillomavirus genotype in cervical cancer.
    BMC Infect Dis. 2017;17:391.
    Abstract    

    Abstract available

  40. KUNCKLER M, Schumacher F, Kenfack B, Catarino R, et al
    Cervical cancer screening in a low-resource setting: a pilot study on an HPV-based screen-and-treat approach.
    Cancer Med. 2017 Jun 4. doi: 10.1002/cam4.1089.
    Abstract    

    Abstract available

  41. MORGAN EL, Sanday K, Budd A, Hammond IG, et al
    Cervical cancer in women under 25 years of age in Queensland, Australia: To what extent is the diagnosis made by screening cytology?
    Aust N Z J Obstet Gynaecol. 2017 Jun 4. doi: 10.1111/ajo.12640.
    Abstract    

    Abstract available

  42. DULLA D, Daka D, Wakgari N
    Knowledge about cervical cancer screening and its practice among female health care workers in southern Ethiopia: a cross-sectional study.
    Int J Womens Health. 2017;9:365-372.
    Abstract    

    Abstract available

  43. SAWAYA GF, Huchko MJ
    Cervical Cancer Screening.
    Med Clin North Am. 2017;101:743-753.
    Abstract    

    Abstract available

  44. MARTINS COSTA E
    Female college students' beliefs about cervical cancer screening.
    Enferm Clin. 2017 May 30. pii: S1130-8621(17)30072.
    Abstract    



  45. KUMAKECH E, Andersson S, Wabinga H, Musubika C, et al
    Cervical cancer risk perceptions, sexual risk behaviors and sexually transmitted infections among Bivalent Human Papillomavirus vaccinated and non-vaccinated young women in Uganda - 5 year follow up study.
    BMC Womens Health. 2017;17:40.
    Abstract    

    Abstract available

  46. LUO L, Xu L, Zhao H
    Biosynthesis of reduced graphene oxide and its in-vitro cytotoxicity against cervical cancer (HeLa) cell lines.
    Mater Sci Eng C Mater Biol Appl. 2017;78:198-202.
    Abstract    

    Abstract available

  47. MIRANDA PY, Yao N, Snipes SA, BeLue R, et al
    Citizenship, length of stay, and screening for breast, cervical, and colorectal cancer in women, 2000-2010.
    Cancer Causes Control. 2017;28:589-598.
    Abstract    

    Abstract available

  48. ONDIC O, Ferko R, Kaspirkova J, Svajdler M Jr, et al
    Bizarre cell dysplasia of the cervix.
    J Obstet Gynaecol Res. 2017;43:345-351.
    Abstract    

    Abstract available

  49. SANSONE M, Saccone G, Migliucci A, Saviano R, et al
    Screening for cervical carcinoma in HIV-infected women: Analysis of main risk factors for cervical cytologic abnormalities.
    J Obstet Gynaecol Res. 2017;43:352-357.
    Abstract    

    Abstract available

  50. KASHIMURA M, Matsuura Y, Kawagoe T, Toki N, et al
    New diagnostic criteria of colposcopy for uterine cervix neoplasia.
    J Obstet Gynaecol Res. 2017;43:339-344.
    Abstract    

    Abstract available

  51. MUNRO A, Codde J, Spilsbury K, Steel N, et al
    Risk of persistent and recurrent cervical neoplasia following incidentally detected adenocarcinoma in situ.
    Am J Obstet Gynecol. 2017;216:272.
    Abstract    

    Abstract available

  52. LI M, Li BY, Xia H, Jiang LL, et al
    Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis.
    Eur Rev Med Pharmacol Sci. 2017;21:2346-2350.
    Abstract    

    Abstract available

  53. WANG FL, Yang Y, Liu ZY, Qin Y, et al
    Correlation between methylation of the p16 promoter and cervical cancer incidence.
    Eur Rev Med Pharmacol Sci. 2017;21:2351-2356.
    Abstract    

    Abstract available

  54. RUZIGANA G, Bazzet-Matabele L, Rulisa S, Martin AN, et al
    Cervical cancer screening at a tertiary care center in Rwanda.
    Gynecol Oncol Rep. 2017;21:13-16.
    Abstract    

    Abstract available

  55. CHEN AH, Qin YE, Tang WF, Tao J, et al
    MiR-34a and miR-206 act as novel prognostic and therapy biomarkers in cervical cancer.
    Cancer Cell Int. 2017;17:63.
    Abstract    

    Abstract available

  56. ZHU J, Shi H, Liu H, Wang X, et al
    Long non-coding RNA TUG1 promotes cervical cancer progression by regulating the miR-138-5p-SIRT1 axis.
    Oncotarget. 2017 May 26. doi: 10.18632/oncotarget.18224.
    Abstract    

    Abstract available

  57. SUN M, Zhang C, Mei W, Yang Y, et al
    [Eukaryotic expression and localization of human MTERF2 in cervical cancer Caski cells].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2017;33:783-788.
    Abstract    

    Abstract available

  58. TANTITAMIT T, Termrungruanglert W, Khemapech N, Havanond P, et al
    A Model Approach for Assessing the Benefits of HPV Testing against Cytology in Screening for Cervical Cancer Precursors in Thailand
    Asian Pac J Cancer Prev. 2017;18:1271-1275.
    Abstract    

    Abstract available

  59. SAQER A, Ghazal Sh, Barqawi H, Babi JA, et al
    Knowledge and Awareness about Cervical Cancer Vaccine (HPV) Among Parents in Sharjah
    Asian Pac J Cancer Prev. 2017;18:1237-1241.
    Abstract    

    Abstract available

  60. DUMOGA S, Rai Y, Bhatt AN, Tiwari AK, et al
    Block copolymer based nanoparticles for theranostic intervention of Cervical Cancer: Synthesis, pharmacokinetics and in-vitro / in-vivo evaluation in HeLa xenograft models.
    ACS Appl Mater Interfaces. 2017 Jun 13. doi: 10.1021/acsami.7b04982.
    Abstract    

    Abstract available

  61. REAL NE, Castro GN, Dario Cuello-Carrion F, Perinetti C, et al
    Molecular markers of DNA damage and repair in cervical cancer patients treated with cisplatin neoadjuvant chemotherapy: an exploratory study.
    Cell Stress Chaperones. 2017 Jun 12. doi: 10.1007/s12192-017-0811.
    Abstract    

    Abstract available

  62. LI CC, Chang TC, Tsai YF, Chen L, et al
    Quality of life among survivors of early-stage cervical cancer in Taiwan: an exploration of treatment modality differences.
    Qual Life Res. 2017 Jun 12. doi: 10.1007/s11136-017-1619.
    Abstract    

    Abstract available

  63. FERRANDINA G, Pedone Anchora L, Gallotta V, Fagotti A, et al
    Can We Define the Risk of Lymph Node Metastasis in Early-Stage Cervical Cancer Patients? A Large-Scale, Retrospective Study.
    Ann Surg Oncol. 2017 Jun 12. doi: 10.1245/s10434-017-5917.
    Abstract    

    Abstract available

  64. BORCOMAN E, Le Tourneau C
    Pembrolizumab in cervical cancer: latest evidence and clinical usefulness.
    Ther Adv Med Oncol. 2017;9:431-439.
    Abstract    

    Abstract available

  65. NDEJJO R, Mukama T, Kiguli J, Musoke D, et al
    Knowledge, facilitators and barriers to cervical cancer screening among women in Uganda: a qualitative study.
    BMJ Open. 2017;7:e016282.
    Abstract    

    Abstract available


  66. Increasing Cervical Cancer Screening in Underserved Populations.
    J Christ Nurs. 2017;34:E49-E50.
    Abstract    



  67. DORSAINVIL MA
    Increasing Cervical Cancer Screening in Underserved Populations.
    J Christ Nurs. 2017;34:152-158.
    Abstract    

    Abstract available

  68. MAHMOUD O, Kilic S, Khan AJ, Beriwal S, et al
    External beam techniques to boost cervical cancer when brachytherapy is not an option-theories and applications.
    Ann Transl Med. 2017;5:207.
    Abstract    

    Abstract available

  69. THOMAS KM, Maquilan G, Stojadinovic S, Medin P, et al
    Reduced toxicity with equivalent outcomes using three-dimensional volumetric (3DV) image-based versus nonvolumetric point-based (NV) brachytherapy in a cervical cancer population.
    Brachytherapy. 2017 Jun 8. pii: S1538-4721(17)30354.
    Abstract    

    Abstract available

  70. LU YF, Fong VH, Wu WY, Wang LY, et al
    Leptomeningeal metastasis of poorly differentiated uterine cervical adenosquamous carcinoma following reirradiation to metastatic vertebrae: A case report.
    Medicine (Baltimore). 2017;96:e6894.
    Abstract    

    Abstract available

  71. CUBO AM, Soto ZM, Cruz MA, Doyague MJ, et al
    Primary diffuse large B cell lymphoma of the uterine cervix successfully treated by combined chemotherapy alone: A case report.
    Medicine (Baltimore). 2017;96:e6846.
    Abstract    

    Abstract available

  72. JULIAO I, Carvalho SD, Patricio V, Raimundo A, et al
    Primary malignant melanoma of the cervix: a rare disease.
    BMJ Case Rep. 2017;2017.
    Abstract    

    Abstract available

  73. BAE SN, Lee KH, Kim JH, Lee SJ, et al
    Zinc induces apoptosis on cervical carcinoma cells by p53-dependent and -independent pathway.
    Biochem Biophys Res Commun. 2017;484:218-223.
    Abstract    

    Abstract available

  74. GRUNBERG MG, Chan M, Adhin MR
    Distinctive distribution of HPV genotypes in cervical cancers in multi-ethnic Suriname: implications for prevention and vaccination.
    Epidemiol Infect. 2017;145:245-253.
    Abstract    

    Abstract available

  75. STEWART CJ, Crook ML
    Cervical intraepithelial neoplasia (CIN) 3-like squamous cell carcinoma of the cervix: a review of 14 cases with comparison of E-cadherin and cyclin D1 expression in the CIN 3-like and infiltrative tumour elements.
    Histopathology. 2017;70:367-374.
    Abstract    

    Abstract available

  76. ZENG Y, Cheng AS, Liu X, Chan CC, et al
    Title: Cervical cancer survivors' perceived cognitive complaints and supportive care needs in mainland China: a qualitative study.
    BMJ Open. 2017;7:e014078.
    Abstract    

    Abstract available

  77. LI P, Tan Y, Zhu LX, Zhou LN, et al
    Prognostic value of HPV DNA status in cervical cancer before treatment: a systematic review and meta-analysis.
    Oncotarget. 2017 Jun 16. doi: 10.18632/oncotarget.18558.
    Abstract    

    Abstract available

  78. PATRA S, Upadhyay M, Chhabra P
    Awareness of cervical cancer and willingness to participate in screening program: Public health policy implications.
    J Cancer Res Ther. 2017;13:318-323.
    Abstract    

    Abstract available

  79. DUMONT A, Bessieres N, Benbassa A, Razafindrafara G, et al
    [Cervical cancer screening in rural Madagascar: Feasibility, coverage and incidence].
    J Gynecol Obstet Hum Reprod. 2017;46:327-332.
    Abstract    

    Abstract available

  80. RAMIREZ PT
    Laparoscopic Resection of Pelvic Sidewall Recurrent Cervical Cancer: Feasibility Does Not Always Equate with Clinical Indication.
    J Minim Invasive Gynecol. 2017 Jun 19. pii: S1553-4650(17)30294.
    Abstract    



  81. DONG W, Li B, Wang J, Song Y, et al
    MicroRNA-337 inhibits cell proliferation and invasion of cervical cancer through directly targeting specificity protein 1.
    Tumour Biol. 2017;39:1010428317711323.
    Abstract    

    Abstract available

  82. LIU HX, Li N, Wei L, Zhou FX, et al
    High expression of Kruppel-like factor 4 as a predictor of poor prognosis for cervical cancer patient response to radiotherapy.
    Tumour Biol. 2017;39:1010428317710225.
    Abstract    

    Abstract available

  83. FERNANDEZ-RETANA J, Zamudio-Meza H, Rodriguez-Morales M, Pedroza-Torres A, et al
    Gene signature based on degradome-related genes can predict distal metastasis in cervical cancer patients.
    Tumour Biol. 2017;39:1010428317711895.
    Abstract    

    Abstract available

  84. YANG J, Fa J, Li B
    APOPTOSIS INDUCTION OF EPIFRIEDELINOL ON HUMAN CERVICAL CANCER CELL LINE.
    Afr J Tradit Complement Altern Med. 2017;14:80-86.
    Abstract    

    Abstract available

  85. LI YB, Wang YL, Zhuo YH
    [Comparison of vacuum bag fixation and Orfit rack with thermoplastic membrane fixation for image-guided cervical cancer radiotherapy].
    Zhonghua Zhong Liu Za Zhi. 2017;39:467-470.
    Abstract    

    Abstract available

  86. HE HY, Yang ZJ, Zeng DY, Yao DS, et al
    [Comparison of the short-term and long-term outcomes of laparoscopic surgery and open surgery for early-stage cervical cancer].
    Zhonghua Zhong Liu Za Zhi. 2017;39:458-466.
    Abstract    

    Abstract available

  87. LI C, Gao N, Xue Q, Ma N, et al
    Screening and identification of a specific peptide binding to cervical cancer cells from a phage-displayed peptide library.
    Biotechnol Lett. 2017 Jun 20. doi: 10.1007/s10529-017-2381.
    Abstract    

    Abstract available

  88. LARSEN MB, Mikkelsen EM, Jeppesen U, Svanholm H, et al
    The influence of total hysterectomy in a cervical cancer screening population: a register-based cross-sectional study.
    BMC Health Serv Res. 2017;17:423.
    Abstract    

    Abstract available

  89. CHATZISTAMATIOU K, Chatzaki Epsilon, Constantinidis Tau, Nena E, et al
    Self-collected cervicovaginal sampling for site-of-care primary HPV-based cervical cancer screening: a pilot study in a rural underserved Greek population.
    J Obstet Gynaecol. 2017 Jun 20:1-6. doi: 10.1080/01443615.2017.1323197.
    Abstract    

    Abstract available

  90. CASTILLO M, Astudillo A, Clavero O, Velasco J, et al
    [Evaluation of mortality after the analysis of the screening history in women diagnosed with infiltrating cervical cancer].
    Aten Primaria. 2017 Jun 16. pii: S0212-6567(16)30269.
    Abstract    

    Abstract available

  91. ZHU Y, Wang Y, Hirschhorn J, Welsh KJ, et al
    Human Papillomavirus and Its Testing Assays, Cervical Cancer Screening, and Vaccination.
    Adv Clin Chem. 2017;81:135-192.
    Abstract    

    Abstract available

  92. HUA F, Liu S, Zhu L, Ma N, et al
    Highly expressed long non-coding RNA NNT-AS1 promotes cell proliferation and invasion through Wnt/beta-catenin signaling pathway in cervical cancer.
    Biomed Pharmacother. 2017;92:1128-1134.
    Abstract    

    Abstract available

  93. DI STEFANO F, Giorgi Rossi P, Carozzi F, Ronco G, et al
    [Implementation of DNA-HPV primary screening in Italian cervical cancer screening programmes. Results of the MIDDIR Project].
    Epidemiol Prev. 2017;41:116-124.
    Abstract    

    Abstract available

  94. LI J, Rao H, Jin C, Liu J, et al
    Involvement of the Toll-Like Receptor/Nitric Oxide Signaling Pathway in the Pathogenesis of Cervical Cancer Caused by High-Risk Human Papillomavirus Infection.
    Biomed Res Int. 2017;2017:7830262.
    Abstract    

    Abstract available

  95. MIYAUCHI R, Itoh Y, Kawamura M, Hirakawa A, et al
    Postoperative chemoradiation therapy using high dose cisplatin and fluorouracil for high- and intermediate-risk uterine cervical cancer.
    Nagoya J Med Sci. 2017;79:211-220.
    Abstract    

    Abstract available

  96. YANG S, Li C, Li X, Huang X, et al
    Relationship of IL-17A and IL-17F genetic variations to cervical cancer risk: a meta-analysis.
    Biomark Med. 2017;11:459-471.
    Abstract    

    Abstract available

  97. TESTA AC, Ferrandina G, Moro F, Pasciuto T, et al
    Prospective multimodal imaging assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery. The PRICE (PRospective Imaging of CErvical cancer and neoadjuvant treatment) study: the role of ultrasou
    Ultrasound Obstet Gynecol. 2017 Jun 16. doi: 10.1002/uog.17551.
    Abstract    

    Abstract available

  98. CHI S, Shen L, Hua T, Liu S, et al
    Prognostic and diagnostic significance of lncRNAs expression in cervical cancer: a systematic review and meta-analysis.
    Oncotarget. 2017 May 31. doi: 10.18632/oncotarget.18323.
    Abstract    

    Abstract available

  99. CAMPOS NG, Mvundura M, Jeronimo J, Holme F, et al
    Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua.
    BMJ Open. 2017;7:e015048.
    Abstract    

    Abstract available

  100. HE H, Lai Y, Hao Y, Liu Y, et al
    Selective p300 inhibitor C646 inhibited HPV E6-E7 genes, altered glucose metabolism and induced apoptosis in Cervical Cancer cells.
    Eur J Pharmacol. 2017 Jun 12. pii: S0014-2999(17)30401.
    Abstract    

    Abstract available

  101. DAMATO AL, Kassick M, Viswanathan AN
    Rectum and bladder spacing in cervical cancer brachytherapy using a novel injectable hydrogel compound (TraceIT).
    Brachytherapy. 2017 Jun 12. pii: S1538-4721(17)30324.
    Abstract    

    Abstract available

  102. YANG T, Aimaiti M, Su D, Miao W, et al
    Enhanced efficacy with reduced toxicity of chemotherapy drug 5-fluorouracil by synergistic treatment with Abnormal Savda Munziq from Uyghur medicine.
    BMC Complement Altern Med. 2017;17:201.
    Abstract    

    Abstract available

  103. FELEFLY T, Mazeron R, Huertas A, Canova CH, et al
    Pelvic radiotherapy in the setting of rheumatoid arthritis: Refining the paradigm.
    Cancer Radiother. 2017;21:109-113.
    Abstract    

    Abstract available

  104. BLAKE DR, Middleman AB
    Human Papillomavirus Vaccine Update.
    Pediatr Clin North Am. 2017;64:321-329.
    Abstract    

    Abstract available

  105. TANG YS, Khan RA, Xiao S, Hansen DK, et al
    Evidence Favoring a Positive Feedback Loop for Physiologic Auto Upregulation of hnRNP-E1 during Prolonged Folate Deficiency in Human Placental Cells.
    J Nutr. 2017;147:482-498.
    Abstract    

    Abstract available

  106. HUERTAS A, Oldrini S, Nesseler JP, Courrech F, et al
    FIGO stage IB1 cervical carcinoma: Place and principles of brachytherapy.
    Cancer Radiother. 2017;21:155-163.
    Abstract    

    Abstract available

  107. YUAN G, Yao H, Li X, Li H, et al
    Stage 1 embryonal rhabdomyosarcoma of the female genital tract: a retrospective clinical study of nine cases.
    World J Surg Oncol. 2017;15:42.
    Abstract    

    Abstract available

  108. SHAN C, Yan JW, Wang YQ, Che T, et al
    Design, Synthesis, and Evaluation of Isaindigotone Derivatives To Downregulate c-myc Transcription via Disrupting the Interaction of NM23-H2 with G-Quadruplex.
    J Med Chem. 2017;60:1292-1308.
    Abstract    

    Abstract available

  109. FARRAYE FA, Melmed GY, Lichtenstein GR, Kane SV, et al
    ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 Jan 10. doi: 10.1038/ajg.2016.
    Abstract    

    Abstract available

  110. FISHMAN J, Taylor L, Frank I
    Awareness of HPV and Uptake of Vaccination in a High-Risk Population.
    Pediatrics. 2016 Jul 20. pii: e20152048.
    Abstract    

    Abstract available

  111. GONZALEZ MF, Akhtar I, Manucha V
    Changing Trends and Practices in Cytopathology.
    Acta Cytol. 2017;61:91-95.
    Abstract    

    Abstract available

  112. CHANDRASEKARAN KS, Sathyanarayanan A, Karunagaran D
    MicroRNA-214 suppresses growth, migration and invasion through a novel target, high mobility group AT-hook 1, in human cervical and colorectal cancer cells.
    Br J Cancer. 2016 Aug 18. doi: 10.1038/bjc.2016.
    Abstract    

    Abstract available

  113. DOXTADER EE, Brainard JA, Underwood D, Chute DJ, et al
    Knowledge of the HPV status biases cytotechnologists' interpretation of Pap tests originally diagnosed as negative for intraepithelial lesion or malignancy.
    Cancer. 2016 Oct 12. doi: 10.1002/cncy.21783.
    Abstract    

    Abstract available

  114. LI Y, Zeng J, Huang M, An J, et al
    A phase 2 study of nanoparticle albumin-bound paclitaxel plus nedaplatin for patients with advanced, recurrent, or metastatic cervical carcinoma.
    Cancer. 2016 Oct 3. doi: 10.1002/cncr.30328.
    Abstract    

    Abstract available

  115. PRINTZ C
    Expert panel issues new global cervical cancer screening guideline.
    Cancer. 2017;123:2387-2388.
    Abstract    



  116. BARROETA JE, Adhikari-Guragain D, Grotkowski CE
    Cervical cancer screening in the era of HPV vaccination: A review of shifting paradigms in cytopathology.
    Diagn Cytopathol. 2017 Jun 6. doi: 10.1002/dc.23737.
    Abstract    

    Abstract available

  117. TRAN PL, Morice P, Chirpaz E, Lazaro G, et al
    Impact of management on mortality in patients with invasive cervical cancer in Reunion Island.
    Eur J Obstet Gynecol Reprod Biol. 2017;215:164-170.
    Abstract    

    Abstract available

  118. MATSUMOTO Y, Mabuchi S, Kozasa K, Kuroda H, et al
    The significance of tumor-associated neutrophil density in uterine cervical cancer treated with definitive radiotherapy.
    Gynecol Oncol. 2017;145:469-475.
    Abstract    

    Abstract available

  119. STEEN R, Dahl AA, Hess SL, Kiserud CE, et al
    A study of chronic fatigue in Norwegian cervical cancer survivors.
    Gynecol Oncol. 2017 May 25. pii: S0090-8258(17)30884.
    Abstract    

    Abstract available

  120. WRIGHT TC JR, Behrens CM, Ranger-Moore J, Rehm S, et al
    Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial.
    Gynecol Oncol. 2017;144:51-56.
    Abstract    

    Abstract available

  121. FRUMOVITZ M, Munsell MF, Burzawa JK, Byers LA, et al
    Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small cell neuroendocrine carcinoma of the cervix.
    Gynecol Oncol. 2017;144:46-50.
    Abstract    

    Abstract available

  122. CHO LP, Manuel M, Catalano P, Lee L, et al
    Outcomes with volume-based dose specification in CT-planned high-dose-rate brachytherapy for stage I-II cervical carcinoma: A 10-year institutional experience.
    Gynecol Oncol. 2016 Oct 6. pii: S0090-8258(16)31423.
    Abstract    

    Abstract available

  123. MISHKIN G, Minasian LM, Kohn EC, Noone AM, et al
    The generalizability of NCI-sponsored clinical trials accrual among women with gynecologic malignancies.
    Gynecol Oncol. 2016 Sep 30. pii: S0090-8258(16)31432.
    Abstract    

    Abstract available

  124. WHITE ID, Sangha A, Lucas G, Wiseman T, et al
    Assessment of sexual difficulties associated with multi-modal treatment for cervical or endometrial cancer: A systematic review of measurement instruments.
    Gynecol Oncol. 2016 Sep 23. pii: S0090-8258(16)31359.
    Abstract    

    Abstract available

  125. WILBUR MB, Mannschreck DB, Angarita AM, Matsuno RK, et al
    Unplanned 30-day hospital readmission as a quality measure in gynecologic oncology.
    Gynecol Oncol. 2016 Sep 21. pii: S0090-8258(16)31426.
    Abstract    

    Abstract available

  126. CHUNG TKH, Cheung TH, Yim SF, Yu MY, et al
    Liquid biopsy of PIK3CA mutations in cervical cancer in Hong Kong Chinese women.
    Gynecol Oncol. 2017 Jun 3. pii: S0090-8258(17)30894.
    Abstract    

    Abstract available

  127. CASTLE PE, Kinney WK, Cheung LC, Gage JC, et al
    Why does cervical cancer occur in a state-of-the-art screening program?
    Gynecol Oncol. 2017 Jun 10. pii: S0090-8258(17)30898.
    Abstract    

    Abstract available

  128. LENNOX GK, Covens A
    Management Of Early Stage Cervical Cancer: When Is Non-Randomized Data Good Enough?
    Gynecol Oncol. 2017;146:1-2.
    Abstract    



  129. KAMRAN SC, Manuel MM, Cho LP, Damato AL, et al
    Comparison of outcomes for MR-guided versus CT-guided high-dose-rate interstitial brachytherapy in women with locally advanced carcinoma of the cervix.
    Gynecol Oncol. 2017;145:284-290.
    Abstract    

    Abstract available

  130. RADER JS, Sill MW, Beumer JH, Lankes HA, et al
    A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study.
    Gynecol Oncol. 2017 Mar 9. pii: S0090-8258(17)30161.
    Abstract    

    Abstract available

  131. DATTA NR, Stutz E, Liu M, Rogers S, et al
    Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer: A systematic review and meta-analysis.
    Gynecol Oncol. 2017;145:374-385.
    Abstract    

    Abstract available

  132. ANGIOLO G, Silvestro C, Giovanni A
    Neuroendrocrine tumors of the uterine cervix: A therapeutic challenge for gynecologic oncologists.
    Gynecol Oncol. 2017 Jan 2. pii: S0090-8258(16)31621.
    Abstract    

    Abstract available

  133. HO D, Drake TK, Smith-McCune KK, Darragh TM, et al
    Feasibility of clinical detection of cervical dysplasia using angle-resolved low coherence interferometry measurements of depth-resolved nuclear morphology.
    Int J Cancer. 2017;140:1447-1456.
    Abstract    

    Abstract available

  134. LASKOW B, Figueroa R, Alfaro KM, Scarinci IC, et al
    A pilot study of community-based self-sampling for HPV testing among non-attenders of cervical cancer screening programs in El Salvador.
    Int J Gynaecol Obstet. 2017 Jun 7. doi: 10.1002/ijgo.12204.
    Abstract    

    Abstract available

  135. PISTA A, de Oliveira CF, Lopes C, Cunha MJ, et al
    Potential impact of nonavalent HPV vaccine in the prevention of high-grade cervical lesions and cervical cancer in Portugal.
    Int J Gynaecol Obstet. 2017 Jun 20. doi: 10.1002/ijgo.12243.
    Abstract    

    Abstract available

  136. SALIHI R, Leunen K, Moerman P, Amant F, et al
    Neoadjuvant Weekly Paclitaxel-Carboplatin Is Effective in Stage I-II Cervical Cancer.
    Int J Gynecol Cancer. 2017 Jun 1. doi: 10.1097/IGC.0000000000001021.
    Abstract    

    Abstract available

  137. CANAZ E, Ozyurek ES, Erdem B, Aldikactioglu Talmac M, et al
    Preoperatively Assessable Clinical and Pathological Risk Factors for Parametrial Involvement in Surgically Treated FIGO Stage IB-IIA Cervical Cancer.
    Int J Gynecol Cancer. 2017 Jun 14. doi: 10.1097/IGC.0000000000001060.
    Abstract    

    Abstract available

  138. POKA R, Molnar S, Darago P, Lukacs J, et al
    Intention-to-Treat Analysis of Radical Trachelectomy for Early-Stage Cervical Cancer With Special Reference to Oncologic Failures: Single-Institutional Experience in Hungary.
    Int J Gynecol Cancer. 2017 Jun 10. doi: 10.1097/IGC.0000000000001048.
    Abstract    

    Abstract available

  139. GULER OC, Sari SY, Birgi SD, Gultekin M, et al
    Definitive Chemoradiotherapy in Elderly Cervical Cancer Patients: A Multiinstitutional Analysis.
    Int J Gynecol Cancer. 2017 Jun 10. doi: 10.1097/IGC.0000000000001029.
    Abstract    

    Abstract available

  140. ECHEVERRIA A, Manley H, O'Donnell B, Asper J, et al
    Factors Associated With Radiation Treatment Compliance for Women With Cervical Cancer in a Safety Net Health System.
    Int J Gynecol Cancer. 2017 Jun 10. doi: 10.1097/IGC.0000000000001035.
    Abstract    

    Abstract available

  141. SONG MK, Shin BS, Ha CS, Park WY, et al
    Would Lipophilic Statin Therapy as a Prognostic Factor Improve Survival in Patients With Uterine Cervical Cancer?
    Int J Gynecol Cancer. 2017 Jun 23. doi: 10.1097/IGC.0000000000001046.
    Abstract    

    Abstract available

  142. ZHU T, Chen X, Zhu J, Chen Y, et al
    Surgical and Pathological Outcomes of Laparoscopic Versus Abdominal Radical Hysterectomy With Pelvic Lymphadenectomy and/or Para-aortic Lymph Node Sampling for Bulky Early-Stage Cervical Cancer.
    Int J Gynecol Cancer. 2017;27:1222-1227.
    Abstract    

    Abstract available

  143. JOO J, Shin HJ, Park B, Park SY, et al
    Integration Pattern of Human Papillomavirus Is a Strong Prognostic Factor for Disease-Free Survival After Radiation Therapy in Cervical Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2017;98:654-661.
    Abstract    

    Abstract available

  144. BJORGE T, Skare GB, Bjorge L, Trope A, et al
    Adverse Pregnancy Outcomes After Treatment for Cervical Intraepithelial Neoplasia.
    Obstet Gynecol. 2016.
    Abstract    

    Abstract available

  145. ZHOU S, Xiao Y, Zhuang Y, Liu Y, et al
    Knockdown of homeobox containing 1 increases the radiosensitivity of cervical cancer cells through telomere shortening.
    Oncol Rep. 2017;38:515-521.
    Abstract    

    Abstract available

  146. LI Y, Zhang J, Han S, Qian Q, et al
    B7-H3 promotes the proliferation, migration and invasiveness of cervical cancer cells and is an indicator of poor prognosis.
    Oncol Rep. 2017 Jun 19. doi: 10.3892/or.2017.5730.
    Abstract    

    Abstract available

  147. XU X, Zou L, Yao Q, Zhang Y, et al
    Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3beta/p-Tyr216-GSK-3beta/beta-catenin axis.
    Oncol Rep. 2017 Jun 14. doi: 10.3892/or.2017.5721.
    Abstract    

    Abstract available

  148. HAYASHI N, Takahashi H, Hasegawa Y, Higuchi F, et al
    A nationwide multi-institutional retrospective study to identify prognostic factors and develop a graded prognostic assessment system for patients with brain metastases from uterine corpus and cervical cancer.
    BMC Cancer. 2017;17:397.
    Abstract    

    Abstract available

  149. BERRAHO M, Amarti-Riffi A, El-Mzibri M, Bezad R, et al
    HPV and cofactors for invasive cervical cancer in Morocco: a multicentre case-control study.
    BMC Cancer. 2017;17:435.
    Abstract    

    Abstract available

  150. XU Y, Zhu L, Liu B, Ru T, et al
    Strain elastography imaging for early detection and prediction of tumor response to concurrent chemo-radiotherapy in locally advanced cervical cancer: feasibility study.
    BMC Cancer. 2017;17:427.
    Abstract    

    Abstract available

  151. SUN XL, Wang HB, Wang ZQ, Cao TT, et al
    Effect of transcutaneous electrical stimulation treatment on lower urinary tract symptoms after class III radical hysterectomy in cervical cancer patients: study protocol for a multicentre, randomized controlled trial.
    BMC Cancer. 2017;17:416.
    Abstract    

    Abstract available

  152. ASIEDU MN, Agudogo J, Krieger MS, Miros R, et al
    Design and preliminary analysis of a vaginal inserter for speculum-free cervical cancer screening.
    PLoS One. 2017;12:e0177782.
    Abstract    

    Abstract available

  153. MARIANO VS, Lorenzi AT, Scapulatempo-Neto C, Stein MD, et al
    A Low-Cost HPV Immunochromatographic Assay to Detect High-Grade Cervical Intraepithelial Neoplasia.
    PLoS One. 2016;11:e0164892.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;